Cingulate (CING) Current Taxes (2022 - 2026)
Cingulate's (CING) quarterly Current Taxes came in at $44000.0 in Q4 2025, down 78.0% YoY from $200000.0 in Q4 2024, and down 39.73% on a QoQ basis from $73000.0 in Q3 2025.
Cingulate (CING) Current Taxes (2022 - 2026) Analysis & Trends
Cingulate (CING) has 4 years of Current Taxes data on file, last reported at $44000.0 in Q4 2025.
- Quarterly Current Taxes fell 78.0% year-over-year to $44000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44000.0 (down 78.0% YoY) and the FY2025 annual result came in at $44000.0, down 78.0% from the prior year.
- Current Taxes slipped to $44000.0 in Q4 2025, from $73000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $200000.0 in Q4 2024 to a low of $34750.0 in Q1 2025.
- A 4-year average of $92416.9 and a median of $80000.0 in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes jumped 112.04% — and 2025, when it slumped 78.0%.
- Tracing CING's Current Taxes over 4 years: stood at $56862.0 in 2022, then jumped by 112.04% to $120570.0 in 2023, then soared by 65.88% to $200000.0 in 2024, then tumbled by 78.0% to $44000.0 in 2025.
- The last three Current Taxes figures came in at $44000.0 (Q4 2025), $73000.0 (Q3 2025), and $102000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cingulate | 72.85 Mn | 72.85 Mn | - | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 34,750.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 120,570.00 |
| Dec 31, 2023 | 120,570.00 |
| Dec 31, 2022 | 56,862.00 |